Samsara Biocapital, LLC

Samsara Biocapital, LLC reported 27 holdings worth US$1.05B as of Sep 30, 2026 (Form 13F)

As of Sep 30, 2026 · Filed Nov 16, 2026

Samsara Biocapital, LLC reported 27 holdings worth US$1.05B as of Sep 30, 2026. Largest: Scholar Rock Holding Corporation, Mineralys Therapeutics, Inc. and Septerna, Inc. Filed Nov 16, 2026 (Form 13F).

Holdings
27
Value as reported
US$1.05B

The filing in full

CompanySharesValue as reported% of portfolio
Scholar Rock Holding Corporation6.9MUS$333M31.7%
Mineralys Therapeutics, Inc.5.87MUS$148M14.0%
Septerna, Inc.3.07MUS$120M11.4%
Alamar Biosciences, Inc.2.48MUS$84.5M8.0%
SpyGlass Pharma, Inc.2.11MUS$54.9M5.2%
Alumis Inc.7.24MUS$53.5M5.1%
Neurogene Inc.1.87MUS$51.9M4.9%
Kalaris Therapeutics, Inc.12.9MUS$37.2M3.5%
Inventiva SA6.31MUS$23.3M2.2%
Parabilis Medicines, Inc.556KUS$18M1.7%
Sutro Biopharma, Inc.1.06MUS$17.1M1.6%
PMV Pharmaceuticals, Inc.7.24MUS$12.1M1.1%
Obsidian Therapeutics, Inc.837KUS$11.5M1.1%
Aquestive Therapeutics, Inc.2.43MUS$11.3M1.1%
vTv Therapeutics Inc.355KUS$10.9M1.0%
Jade Biosciences, Inc.736KUS$10.3M0.98%
Nkarta, Inc.3.51MUS$9.19M0.87%
Rani Therapeutics Holdings, Inc.10.4MUS$8.2M0.78%
Artiva Biotherapeutics, Inc.955KUS$6.8M0.65%
AgomAb Therapeutics NV595KUS$6.6M0.63%
Eloxx Pharmaceuticals, Inc.400KUS$6.12M0.58%
Abivax SA55,095US$5.46M0.52%
Coherus Oncology, Inc.3.38MUS$4.09M0.39%
X4 Pharmaceuticals, Inc.1.35MUS$3.91M0.37%
Upstream Bio, Inc.300KUS$1.58M0.15%
TCGX Acquisition Corp.100KUS$1.25M0.12%
Gossamer Bio, Inc.0US$00.00%

Source

Download original · View original at SEC

Related